Pax3 transcripts in melanoblast development

The transcription factor encoded by PAX3 is among the first expressed in the embryo, with a key role in development of the melanocytic lineage. Re‐expression of PAX3, consistently observed in cutaneous malignant melanoma (CMM) as compared to normal melanocytes, appears linked to progression of CMM....

Full description

Saved in:
Bibliographic Details
Published inDevelopment, growth & differentiation Vol. 47; no. 9; pp. 627 - 635
Main Authors Blake, Judith A., Ziman, Mel R.
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.12.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The transcription factor encoded by PAX3 is among the first expressed in the embryo, with a key role in development of the melanocytic lineage. Re‐expression of PAX3, consistently observed in cutaneous malignant melanoma (CMM) as compared to normal melanocytes, appears linked to progression of CMM. Previous research has identified PAX3d (encoded by exons 1–9) as the predominant isoform present in CMM, together the with an alternate isoform PAX3c (encoded by exons 1–8). We investigated the expression of Pax3c and Pax3d transcripts during mouse development. The reverse transcription–polymerase chain reaction and immunohistochemistry experiments presented here implicate these transcripts in melanoblast development and demonstrate significant spatial and temporal differences in their expression. Differences in expression were also noted during active hair regrowth in adult skin, which is accompanied by proliferation and migration of melanoblasts into the hair cortex to color new hair. Results indicate that the defined spatial and temporal expression of Pax3d may be linked to either melanoblast proliferation or migration during melanogenesis.
Bibliography:J. A. B. contributed 60% and M. R. Z. contributed 40% to this publication.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0012-1592
1440-169X
DOI:10.1111/j.1440-169X.2005.00835.x